Literature DB >> 17996280

Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.

Bethan Freestone1, Aun Yeong Chong, Sarah Nuttall, Gregory Y H Lip.   

Abstract

BACKGROUND: Impaired endothelial-dependent flow-mediated dilatation (FMD) has been used to demonstrate endothelial dysfunction in a wide variety of cardiovascular disease, but previous studies have excluded patients with atrial fibrillation(AF). We therefore hypothesised that endothelial dysfunction exists in AF and that this could be demonstrated by impaired FMD, and related to plasma indices of endothelial damage/dysfunction [soluble E-selectin (sE-sel), von Willebrand factor (vWf), and soluble thrombomodulin (sTM)], as well as total body nitrate/nitrite product (NOx, a measure of endothelial nitric oxide production).
METHODS: We studied 40 patients with chronic permanent AF, who were compared to 26 sinus rhythm controls. Patients with AF were stable on rate-control and antithrombotic medication and were fasted for the study. High-resolution ultrasound was used to measure right brachial artery diameter at rest, during reactive hyperaemia (endothelium-dependent flow-mediated dilatation) and following endothelium-independent, GTN-mediated dilatation.
RESULTS: Baseline brachial artery diameter did not differ significantly between AF and healthy control subjects. FMD was significantly impaired in AF patients in comparison to healthy controls (8.9% in controls vs 0.0% in AF, p<0.0001). There was no significant difference in endothelium-independent (GTN-induced) dilatation between the groups. Only AF and male sex were independent predictors of impaired FMD on stepwise multiple regression analysis(p<0.0001). sE-sel and vWf were higher in AF than controls (p<0.05), and NOx levels did not reach significance (p=0.1416).
CONCLUSIONS: Endothelial dysfunction, as demonstrated by impairment of FMD and raised vWF and E-selectin, is present in AF. Such endothelial perturbation may contribute to the increased risk of stroke and thromboembolism in this common arrhythmia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996280     DOI: 10.1016/j.thromres.2007.09.008

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  15 in total

1.  α-galactosidase A deficiency promotes von Willebrand factor secretion in models of Fabry disease.

Authors:  Justin J Kang; Nayiri M Kaissarian; Karl C Desch; Robert J Kelly; Liming Shu; Peter F Bodary; James A Shayman
Journal:  Kidney Int       Date:  2018-11-22       Impact factor: 10.612

2.  Brachial flow-mediated dilation and incident atrial fibrillation: the multi-ethnic study of atherosclerosis.

Authors:  Wesley T O'Neal; Jimmy T Efird; Joseph Yeboah; Saman Nazarian; Alvaro Alonso; Susan R Heckbert; Elsayed Z Soliman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-23       Impact factor: 8.311

Review 3.  Peripheral artery disease and atrial fibrillation: a potentially dangerous combination.

Authors:  Francesco Violi; Gregory Y H Lip; Stefania Basili
Journal:  Intern Emerg Med       Date:  2011-06-11       Impact factor: 3.397

Review 4.  Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation.

Authors:  Abhishek Maan; Amir Y Shaikh; Moussa Mansour; Jeremy N Ruskin; E Kevin Heist
Journal:  J Atr Fibrillation       Date:  2012-06-15

5.  Preventive effect of rosiglitazone on liver injury in a mouse model of decompression sickness.

Authors:  Bin Peng; Miao-Miao Chen; Zheng-Lin Jiang; Xia Li; Guo-Hua Wang; Li-Hua Xu
Journal:  Diving Hyperb Med       Date:  2017-03       Impact factor: 0.887

6.  Left ventricular native T1 time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation.

Authors:  Shingo Kato; Murilo Foppa; Sébastien Roujol; Tamer Basha; Sophie Berg; Kraig V Kissinger; Beth Goddu; Warren J Manning; Reza Nezafat
Journal:  Int J Cardiol       Date:  2015-11-11       Impact factor: 4.164

7.  Atrial fibrillation pacing decreases intravascular shear stress in a New Zealand white rabbit model: implications in endothelial function.

Authors:  Nelson Jen; Fei Yu; Juhyun Lee; Steve Wasmund; Xiaohu Dai; Christina Chen; Pai Chawareeyawong; Yongmo Yang; Rongsong Li; Mohamed H Hamdan; Tzung K Hsiai
Journal:  Biomech Model Mechanobiol       Date:  2012-09-15

Review 8.  Von Willebrand Factor Plasma Levels Variability In Nonvalvular Atrial Fibrillation.

Authors:  Gerardo Muñoz Cortés; Martha Eva Viveros Sandoval; Carlos Arturo Areán Martínez; Helios Eduardo Vega Gómez; Sandra Edith López Castañeda; Anel Gómez García
Journal:  J Atr Fibrillation       Date:  2014-12-31

Review 9.  Endothelial function in patients with atrial fibrillation.

Authors:  Ahsan A Khan; Graham N Thomas; Gregory Y H Lip; Alena Shantsila
Journal:  Ann Med       Date:  2020-01-10       Impact factor: 4.709

Review 10.  Atrial fibrillation: effects beyond the atrium?

Authors:  Rohan S Wijesurendra; Barbara Casadei
Journal:  Cardiovasc Res       Date:  2015-01-12       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.